Nomura Holdings’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Buy
21,165
+19,891
+1,561% +$9.55M 0.01% 525
2026
Q1
$626K Sell
1,274
-4,521
-78% -$2.45M ﹤0.01% 1299
2025
Q4
$3.36M Sell
5,795
-5,610
-49% -$3.17M ﹤0.01% 920
2025
Q3
$5.53M Buy
11,405
+8,412
+281% +$3.92M 0.01% 732
2025
Q2
$1.21M Sell
2,993
-10,783
-78% -$4.51M ﹤0.01% 945
2025
Q1
$6.85M Sell
13,776
-1,651
-11% -$894K 0.01% 591
2024
Q4
$8.03M Buy
15,427
+9,899
+179% +$5.44M 0.01% 589
2024
Q3
$3.42M Sell
5,528
-2,608
-32% -$1.54M 0.01% 786
2024
Q2
$4.5M Buy
8,136
+3,103
+62% +$1.78M 0.01% 686
2024
Q1
$2.93M Sell
5,033
-23,236
-82% -$13M 0.01% 793
2023
Q4
$15M Buy
+28,269
New +$13.7M 0.04% 343
2023
Q3
Sell
-18,361
Closed -$9.58M 1643
2023
Q2
$9.58M Buy
18,361
+17,668
+2,549% +$9.53M 0.03% 348
2023
Q1
$399K Sell
693
-19,393
-97% -$10.9M ﹤0.01% 1169
2022
Q4
$11.1M Buy
+20,086
New +$10.6M 0.05% 293
2022
Q3
Sell
-625
Closed -$343K 1960
2022
Q2
$343K Sell
625
-12,115
-95% -$6.67M ﹤0.01% 1199
2022
Q1
$7.55M Buy
12,740
+5,234
+70% +$3.01M 0.02% 498
2021
Q4
$5.01M Buy
7,506
+191
+3% +$119K 0.01% 699
2021
Q3
$4.19M Buy
7,315
+1,369
+23% +$751K 0.01% 678
2021
Q2
$3M Sell
5,946
-740
-11% -$349K 0.01% 729
2021
Q1
$3.05M Sell
6,686
-55,886
-89% -$26.7M 0.01% 713
2020
Q4
$29.1M Sell
62,572
-5,609
-8% -$2.63M 0.05% 207
2020
Q3
$30M Buy
68,181
+61,146
+869% +$25.3M 0.07% 175
2020
Q2
$2.55M Buy
+7,035
New +$2.36M 0.01% 515
2020
Q1
Sell
-167,585
Closed -$54.4M 1213
2019
Q4
$54.4M Buy
167,585
+135,709
+426% +$41.1M 0.2% 83
2019
Q3
$9.17M Sell
31,876
-65,711
-67% -$18.8M 0.03% 339
2019
Q2
$29.2M Buy
97,587
+72,710
+292% +$20M 0.13% 137
2019
Q1
$6.87M Sell
24,877
-27,084
-52% -$6.74M 0.03% 386
2018
Q4
$11.6M Buy
51,961
+22,585
+77% +$5.3M 0.04% 292
2018
Q3
$7.3M Sell
29,376
-18,105
-38% -$4.17M 0.03% 421
2018
Q2
$9.84M Sell
47,481
-27,720
-37% -$5.88M 0.03% 371
2018
Q1
$15.5K Buy
75,201
+3,810
+5% +$800K 0.03% 307
2017
Q4
$13.6M Buy
71,391
+32,039
+81% +$6.14M 0.02% 381
2017
Q3
$7.45M Buy
39,352
+9,712
+33% +$1.76M 0.02% 458
2017
Q2
$5.17M Buy
29,640
+27,526
+1,302% +$4.62M 0.01% 535
2017
Q1
$325K Sell
2,114
-20,545
-91% -$3.14M ﹤0.01% 1061
2016
Q4
$3.2M Buy
+22,659
New +$3.34M 0.01% 717
2016
Q2
Sell
-3,411
Closed -$482K 1621
2016
Q1
$482K Sell
3,411
-65,730
-95% -$8.81M ﹤0.01% 891
2015
Q4
$9.79M Buy
69,141
+65,486
+1,792% +$8.73M 0.03% 254
2015
Q3
$445K Sell
3,655
-7,080
-66% -$922K ﹤0.01% 1016
2015
Q2
$1.38M Buy
10,735
+7,456
+227% +$972K ﹤0.01% 950
2015
Q1
$436K Sell
3,279
-32,990
-91% -$4.25M ﹤0.01% 1135
2014
Q4
$4.53M Buy
36,269
+32,085
+767% +$3.9M 0.01% 652
2014
Q3
$508K Buy
4,184
+1,435
+52% +$174K ﹤0.01% 1808
2014
Q2
$324K Sell
2,749
-257,362
-99% -$30.3M ﹤0.01% 2071
2014
Q1
$31.3M Buy
260,111
+221,503
+574% +$26.3M 0.01% 204
2013
Q4
$4.29M Sell
38,608
-21,923
-36% -$2.18M 0.02% 437
2013
Q3
$5.58M Buy
60,531
+25,894
+75% +$2.34M 0.03% 432
2013
Q2
$2.94M Buy
+34,637
New +$2.88M 0.02% 497

Other funds holding TMO

Nomura Holdings's TMO Position: Q2 2026 in Review

Nomura Holdings increased its Thermo Fisher Scientific (TMO) stake by 1,561% in Q2 2026, buying an estimated $9.55M and bringing the position to 21,165 shares worth $10.6M. The position accounts for 0.01% of the portfolio, ranked #525.

Nomura Holdings first reported a position in TMO in Q2 2013 and has held it in 48 quarters since. The position peaked at $54.4M in Q4 2019. 2,508 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Nomura Holdings held 21,165 shares of Thermo Fisher Scientific worth $10.6M as of Q2 2026.
  • Nomura Holdings bought 19,891 Thermo Fisher Scientific shares in Q2 2026, an estimated $9.55M.
  • Thermo Fisher Scientific made up 0.01% of Nomura Holdings's portfolio in Q2 2026, its #525 holding.
  • Nomura Holdings first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 48 quarters since.
  • Nomura Holdings's Thermo Fisher Scientific position peaked at $54.4M in Q4 2019.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.